Showing results (211-220 of 282) with videos related to

Sort By:
Pageof 29
JAAD International|February 24, 2022
Risk factors for hand eczema in the general population of Saudi Arabia during the COVID-19 pandemic: An internet-based cross-sectional studyAzzam Alkhalifah
JAAD International|February 24, 2022
Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic reviewYuliya Lytvyn, Katherine McDonald, Asfandyar Mufti, et al.
JAAD International|May 2, 2022
Trends in dermatology eponymsLin He, Toby C Cornish, Larry J Kricka, et al.
JAAD International|March 4, 2022
Survival outcomes and epidemiology of Merkel cell carcinoma of the lower limb and hip: A Surveillance, Epidemiology, and End Results analysis 2000-2018Matteo Scampa, Rastine Merat, Evangelia Tzika, et al.
JAAD International|November 30, 2023
Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysisMitchell F Brin, Koen De Boulle, Steven Liew, et al.
JAAD International|September 15, 2023
Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: A multicenter cohort studyHannah L Cornman, Junwen Deng, Anusha Kambala, et al.
JAAD International|September 4, 2023
Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement NetworkMarina Z Joel, Matthew T Taylor, Hannah L Cornman, et al.
JAAD International|January 6, 2022
A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysisNorito Katoh, Yukihiro Ohya, Hiroyuki Murota, et al.
JAAD International|January 21, 2022
Cutaneous balamuthiasis: A clinicopathological studyPatricia Alvarez, Carlos Torres-Cabala, Eduardo Gotuzzo, et al.
JAAD International|November 24, 2021
Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysisHelen Y Sun, Elena Keller, Harish Suresh, et al.
Pageof 29